Global radiodermatitis market was valued at USD 310.9 Million in 2016. It is expected to grow at a 4.0% CAGR during the forecast period. Radiation therapy is causing radiodermatitis to increase in the market. The increasing number of patients suffering from radiodermatitis as an adverse effect of radiation therapy has created a high demand for radiodermatitis treatments. In the end, radiodermatitis products have seen a dramatic increase in popularity, which has led to rapid market growth.
U.S. Radiodermatitis Market by Product, 2014-2025 (USD Million).
The American Society for Radiation Oncology has presented statistics that show approximately 95% of radiation therapy patients suffer from some form of radiodermatitis. However, 85% of total patients experience severe or moderate radiodermatitis and require intensive treatment. This will increase the global use of radiodermatitis treatments.
This market is driven by the increasing number of private and public healthcare providers that are constantly striving to raise awareness about radiodermatitis management. These organizations also provide guidelines and recommendations for effective treatment, which will increase the market's potential growth over the forecast period.
The BC Cancer Agency, a provincial agency of the Provincial Health Services Authority issued guidelines regarding radiodermatitis symptoms management and information about radiodermatitis risk factors. This will increase awareness about assessment and treatment procedures, as well as general skincare recommendations, which is expected to fuel growth potential.
There are increasing numbers of clinical trials being conducted to determine the effectiveness of various radiodermatitis treatments. This will increase the market's product portfolio and provide lucrative growth opportunities. In 2010, products like Aquaphor, Calendula, RadiaCare and Biafine were evaluated for their effectiveness in minimizing high-level radiation burns.
The largest market share, at over 70%, was captured by the topical products segment in 2016. This large share can be attributed to the many benefits associated with topical products. These benefits include ease of application, availability, high cost-efficiency, and easy use. They are expected to be the main factors driving the adoption of these products in the past years.
Topical products also reduce the risk for microbial transmission and protect the skin from abrasive substances. This segment includes hydrophilic creams and corticosteroids. Because they are considered the gold standard for treating inflammatory skin conditions and encourage their adoption for radiodermatitis treatment, corticosteroids accounted the highest share of all topical agents.
Due to the availability of many products on the market, dressings will see a moderate increase in demand over the next few years. There are many options available, including foam-based, hydrogel and hydrocolloid, silicon-coated, silver leaf dressings, as well as silicone-coated. The effectiveness of dressings for treating different types of radiation burns has been demonstrated. This is expected to increase their popularity in the future.
Because of the many benefits, hydrogel and hydrocolloid dressings have been increasingly used to treat radiation burns. Hydrogel & hydrocolloid dressings offer many benefits, including a high level of protection against bacteria growth and speedy healing. The future growth prospects of this market will be enhanced by the availability of many products that cater to the different needs of patients.
In 2016, the largest share of the distribution channel segment was held by retail pharmacy. This large share can be attributed largely to the accessibility and affordability of retail pharmacies. Patients are encouraged to use retail pharmacies because they offer affordable drug cost reimbursement. This increases market growth potential.
The growth of online pharmacies is expected to be rapid. This is due to several benefits, such as greater convenience for patients who are unable to buy medicines from hospital pharmacies or retail pharmacies.
Due to the high prevalence of chronic illnesses, there is a gap between the supply and demand for drugs of high significance. These factors will increase the demand for online pharmacies during the forecast period.
Market share of global radiodermatitis by distribution channel, 2016, (%)
Online pharmacies make it easy to order and track orders. Associative supply chain management (SCM), which eliminates market intermediaries, reduces overall drug prices, and drives customers to opt for online medicine shopping.
Asia Pacific dominated the market in 2016. This region has a significant share of the market due to its growing cancer patient population. This region also enjoys a greater share of the market due to extensive collaborations with key players in order to expand their product portfolio expansion capabilities.
Established pharmaceutical companies are heavily involved in the commercialization and promotion of their products among the end users. This region is driven by key growth factors such as favorable government initiatives to support research activities, and increased outsourcing by developed countries.
North America accounted for the second largest share of radiodermatitis markets. The market is primarily driven by the high R&D investments made by global players, and their determination to be competitive in the market. The region's significant growth potential is also due to its high disposable income and sophisticated healthcare infrastructure.
Key players are implementing sustainability strategies extensively to create a competitive environment. ConvaTec, Inc., Molnlycke Health Care AB, Smith & Nephew and 3M Healthcare are the major players in radiodermatitis. These companies focus on strategies such as mergers and acquisitions, new product development initiatives and geographic expansion.
ConvaTec, for example, launched FoamLite in September 2016. This thin, breathable, silicone adhesive-based dressing has silicone adhesives. It increases the number of silicone foam dressings available for burn treatment, including radiation burns. The company expects this initiative to increase its share in the future.
ConvaTec also launched new sizes of its AQUACEL Foam dressings in May 2016. This product launch was an effort to increase product penetration, expand geographic presence, and cater for a wider patient base. This product was launched in France, Canada, Malaysia, Canada and the Netherlands.
This report predicts revenue growth at the global, regional and country levels. It also analyzes the industry trends for each sub-segment from 2014 through 2025. Grand View Research divided the radiodermatitis market by product, distribution channel, region.
Product Outlook (Revenue USD Million, 2014-2025)
Topical
Corticosteroids
Hydrophilic creams
Antibiotics
Other
Oral
Dressings
Hydrogel & hydrocolloid dressings
No sting barrier film
Honey-impregnated gauze
Silicone-coated dressings
Other
Distribution Channel Outlook (Revenue USD Million, 2014-2025)
Hospital Pharmacy
Retail Pharmacy
Online
Regional Outlook (Revenue USD Million, 2014-2025)
North America
The U.S.
Canada
Europe
The U.K.
Germany
Asia Pacific
Japan
China
India
Latin America
Mexico
Brazil
The Middle East & Africa
South Africa
b. Global Radiodermatitis market was valued at USD 347.2 Million in 2019, and is forecast to grow to USD 360.8 Million in 2020.
What is the radiodermatitis industry growth?b. Global Radiodermatitis Market is expected to grow at a compound annual rate of 4.0% between 2018 and 2025, reaching USD 442.1 Million by 2025.
Which segment had the largest radiodermatitis market shares?b. Asia Pacific was the dominant market for radiodermatitis in 2019, with a share of 45 percent. This can be attributed to the growing cancer patient population in the region, strong collaborations between key players, favorable government initiatives, and an increase in outsourced services in the region.
Which are the major players in the radiodermatitis marketb. 3M Healthcare, ConvaTec, Inc., Molnlycke Health Care AB, Smith & Nephew are some of the key players in the Radiodermatitis industry. Radiotherapy treatment has led to radiodermatitis. There are also rising numbers of private and public healthcare providers.
What are the driving factors for the radiodermatitis industry?b. The market is growing due to the increasing prevalence of radiodermatitis from radiotherapy treatment, the rising number of private & public healthcare organizations and the rising number of clinical trials that have been conducted to expand the product portfolio.
Up Market Research published a new report titled “Radiodermatitis Market research report which is segmented by Product (Silicone Coated, No Sting Barrier Film, Dressings, Antibiotics, Corticosteroids, Topical, Hydrophilic Creams, Hydrogel & Hydrocolloid), By Players/Companies 3M Healthcare; ConvaTec, Inc;M¶lnlycke Health Care AB; and Smith & Nephew lence of radiodermatitis due to radiotherapy treatment, Rising number of public & private healthcare organizations and Rising number of clinics”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.
Report Attributes | Report Details |
Report Title | Radiodermatitis Market Research Report |
By Product | Silicone Coated, No Sting Barrier Film, Dressings, Antibiotics, Corticosteroids, Topical, Hydrophilic Creams, Hydrogel & Hydrocolloid |
By Companies | 3M Healthcare; ConvaTec, Inc;M¶lnlycke Health Care AB; and Smith & Nephew lence of radiodermatitis due to radiotherapy treatment, Rising number of public & private healthcare organizations and Rising number of clinics |
Regions Covered | North America, Europe, APAC, Latin America, MEA |
Base Year | 2020 |
Historical Year | 2018 to 2019 (Data from 2010 can be provided as per availability) |
Forecast Year | 2028 |
Number of Pages | 234 |
Number of Tables & Figures | 164 |
Customization Available | Yes, the report can be customized as per your need. |
The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.
The market is segmented by Product (Silicone Coated, No Sting Barrier Film, Dressings, Antibiotics, Corticosteroids, Topical, Hydrophilic Creams, Hydrogel & Hydrocolloid).
Radiodermatitis Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.
Key Benefits for Industry Participants & Stakeholders:
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.
We have studied the Radiodermatitis Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.
How you may use our products:
Reasons to Purchase the Radiodermatitis Market Report:
Some other reports from this category!